Increasing Global And National Knowledge About Illicit Drug Use, Harms And Effective Interventions
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
This Fellowship aims to increase global and national knowledge about drug use and related harms, and interventions to prevent harm and improve public health. It will create new knowledge that will be used by UN and international agencies, and national governments, to monitor changes in drug use and harms, and guide policy and planning for drug treatment and harm reduction services.
Monitoring And Improving The Health Of Ex-prisoners
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
More than 50,000 people are released from prison in Australia each year. Ex-prisoners experience high rates of chronic disease, social disadvantage, mental illness, drug dependence and premature death, yet we know almost nothing about how to improve their health outcomes. This program of research will identify key health issues for ex-prisoners and generate evidence-based responses, simultaneously improving health and reducing reoffending among this highly marginalised group.
Goodness-of-fit Testing And Extensions Of Relative Risk Models
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
Information about the health consequences of exposure to causal factors is obtained from mathematical models of observed data. Relative risk models are recommended for observations over time on a cohort of subjects, but it is not known how best to assess the adequacy of such models or whether they can be applied to ordered outcomes or multiple measurements on the same individuals. These research aims to address those issues, and thereby to increase the practical usefulness of these models.
Integrating Population Genetics, In Silico And Functional Data To Enable Precision Medicine In The Epilepsies
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Epilepsy has proven to be a very genetically tractable neurological disorder. However, while we now routinely identify causal mutations in out patient populations, the process of understanding which are contributing versus which are benign background variation becomes critical as we move towards a period where precision medicine is becoming a reality for some patients. This work will focus on bringing together multiple levels of data to explore integrated models of predicting epilepsy variants.
VACCINE SAFETY RESEARCH In Understudied And At Risk Groups: Critical Knowledge To Inform Practice And Policy.
Funder
National Health and Medical Research Council
Funding Amount
$290,041.00
Summary
Vaccines are typically given to healthy individuals and therefore safety issues loom high on the list of public concerns. Vaccine hesitancy due to safety concerns is an issue of increasing global interest and threatens to lower vaccine uptake. My research aims to understand why some people experience adverse reactions to vaccines, do genetic markers exist?, what are the long term outcomes of a vaccine reaction and how best to communicate vaccine risk/safety to the Australian community.
Understanding And Preventing Population-level Harm From Alcohol
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
This project will support Dr Livingston's world-leading work to better understand the reasons that alcohol consumption and related-harm changes at the population level. It will also support projects that will directly assess the impact of changes to alcohol policies in Australia and the development of policy simulation models, to provide critical evidence and ensure well-informed policy decisions can be made to reduce alcohol-related harm.
International Strategies To Reduce Population Salt Intake
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Effective, sustainable and scalable strategies to reduce salt are needed so countries can achieve the global target to reduce salt by 30% by 2025. This research program will support the optimal development of such strategies through trials and intervention research projects, supplemented through a series of systematic reviews and feasibility and cost-effectiveness assessments. The main outcome will be new evidence on the effectiveness of different interventions to support translation globally.
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15), CCAAT/enhancer Binding Protein Delta (CEBPD) And Neuroinflammtion
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
I will develop new therapies for multiple sclerosis and spinal cord injury. I will also evaluate diagnostic and therapeutic uses for macrophage inhibitory cytokine-1 (MIC-1/GDF15) that was discovered in Australia. I will confirm its use in screening for bowel cancer. Also, I will look at using it in the indigenous and wider Australian community to improve health and close the gap in life expectancy. Finally, I will conduct trials of MIC-1/GDF15 therapy of obesity and inflammation.